Ketamine One Expands to Veteran-Centric Markets in Canada The Preface In 2019, Health Canada approved the NeuroCatch Platform, a medical device developed by HealthTech Connex that measures cognitive brain functions. NeuroCatch is currently in use …

MAPS-sponsored study on MDMA for PTSD by Numinus gets the go-ahead from Health Canada Vancouver’s Numinus Wellness announced that Health Canada issued a No Objection Letter to the company, giving them federal approval to proceed …

</pre> Therapy in the UK There’s a good chance mental health patients in the UK will soon have access to world-class psychedelic therapy thanks to a powerful partnership.  COMPASS Pathways (NASDAQ: CMPS) has been collaborating …

</pre> Harvard Law group to study the legal implications of psychedelics  Touted as yet another sign that psychedelics are being accepted into the mainstream, Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and …

</pre> Hacking Your Virtual Mind Los Angeles-based startup Tripp has been developing a breakthrough wellness platform to hack your mind via interactive, immersive VR and mobile experiences. What Tripp Offers: Relaxation exercises to blend experiences …

</pre> Hardships of a Critical Workforce Canadian non-profit Therapsil is advocating for doctors and therapists to legally trip on mushrooms. They’re joined by initiatives from Novamind and Cybin to highlight healthcare workers. Focus will remain …